Nielsen EB - Search Results

1

(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier.

Braestrup C, Nielsen EB, Sonnewald U, Knutsen LJ, Andersen KE, Jansen JA, Frederiksen K, Andersen PH, Mortensen A, Suzdak PD. Braestrup C, et al. Among authors: nielsen eb. J Neurochem. 1990 Feb;54(2):639-47. doi: 10.1111/j.1471-4159.1990.tb01919.x. J Neurochem. 1990. PMID: 2299358

2

The synthesis of novel GABA uptake inhibitors. 1. Elucidation of the structure-activity studies leading to the choice of (R)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]-3-piperidinecarboxylic acid (tiagabine) as an anticonvulsant drug candidate.

Andersen KE, Braestrup C, Grønwald FC, Jørgensen AS, Nielsen EB, Sonnewald U, Sørensen PO, Suzdak PD, Knutsen LJ. Andersen KE, et al. Among authors: nielsen eb. J Med Chem. 1993 Jun 11;36(12):1716-25. doi: 10.1021/jm00064a005. J Med Chem. 1993. PMID: 8510100

3

NNC-711, a novel potent and selective gamma-aminobutyric acid uptake inhibitor: pharmacological characterization.

Suzdak PD, Frederiksen K, Andersen KE, Sørensen PO, Knutsen LJ, Nielsen EB. Suzdak PD, et al. Among authors: nielsen eb. Eur J Pharmacol. 1992 Dec 2;224(2-3):189-98. doi: 10.1016/0014-2999(92)90804-d. Eur J Pharmacol. 1992. PMID: 1468507

4

Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.

Nielsen EB, Suzdak PD, Andersen KE, Knutsen LJ, Sonnewald U, Braestrup C. Nielsen EB, et al. Eur J Pharmacol. 1991 Apr 24;196(3):257-66. doi: 10.1016/0014-2999(91)90438-v. Eur J Pharmacol. 1991. PMID: 1832636

5

Future directions in anxiety research.

Braestrup C, Nielsen EB. Braestrup C, et al. Among authors: nielsen eb. Psychopharmacol Ser. 1988;5:180-6. doi: 10.1007/978-3-642-73280-5_17. Psychopharmacol Ser. 1988. PMID: 2901081 Review.

6

[3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site.

Andersen PH, Jansen JA, Nielsen EB. Andersen PH, et al. Among authors: nielsen eb. Eur J Pharmacol. 1987 Nov 24;144(1):1-6. doi: 10.1016/0014-2999(87)90002-1. Eur J Pharmacol. 1987. PMID: 3436357

7

Synthesis and binding properties of [3H]NNC 12-0781, a new radioligand for the dopamine reuptake system.

Müller L, Hall H, Halldin C, Farde L, Hohlweg R, Suzdak PD, Nielsen EB, Foged C. Müller L, et al. Among authors: nielsen eb. Nucl Med Biol. 1995 Aug;22(6):711-7. doi: 10.1016/0969-8051(95)00011-l. Nucl Med Biol. 1995. PMID: 8535331

8

Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists.

Nielsen EB, Andersen PH. Nielsen EB, et al. Eur J Pharmacol. 1992 Aug 14;219(1):35-44. doi: 10.1016/0014-2999(92)90577-q. Eur J Pharmacol. 1992. PMID: 1397048

9

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.

Andersen PH, Grønvald FC, Hohlweg R, Hansen LB, Guddal E, Braestrup C, Nielsen EB. Andersen PH, et al. Among authors: nielsen eb. Eur J Pharmacol. 1992 Aug 14;219(1):45-52. doi: 10.1016/0014-2999(92)90578-r. Eur J Pharmacol. 1992. PMID: 1397049

10

Drug discrimination approaches to the behavioral role of the D-1 receptor.

Nielsen EB, Andersen PH. Nielsen EB, et al. J Psychopharmacol. 1992 Jan;6(1):43-9. doi: 10.1177/026988119200600110. J Psychopharmacol. 1992. PMID: 22291241 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page